US EditionPublished • loading... • Updated
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 4,000 Shares
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 4,000 Shares
United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 4,000 shares of the company’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $467.55, for a total transaction of $1,870,200.00. Following the completion of the sale, the chief executive officer directly owned 130 shares […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
